Firas Hamdan

8PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 28, 2026
Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.

Firas Hamdan, Sara Gandolfi, Federica D'Alessio

|Nov 12, 2025
Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.

Salvatore Russo, Yvonne Giannoula, Sara Feola

|Mar 08, 2024
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.

Sara Feola, Firas Hamdan, Salvatore Russo

|Nov 04, 2023
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.

Jacopo Chiaro, Gabriella Antignani, Sara Feola

|Sep 12, 2023
Personalizing Oncolytic Virotherapy.

Firas Hamdan, Manlio Fusciello, Vincenzo Cerullo

|Aug 07, 2021
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids.

Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro

Pageof 2

Frequent Collaborators

7 joint publications

Vincenzo Cerullo

5 joint publications

Sara Feola

5 joint publications

Manlio Fusciello

3 joint publications

Jeanette Leusen